E20-E35 — Disorders of other endocrine glands
Every ICD-10-CM code in this range and the PDGM clinical group CMS assigns to it, read from the CMS grouper crosswalk v07.1.26.
Codes in range
99
No clinical group
21
A period cannot be grouped from these.
Barred as primary
0
CMS rejects these in the primary position.
Where these codes group
64 of the 99 codes in E20-E35 group to MMTA - Endocrine, but the range is not uniform — it spreads across 2 clinical groups. A further 21 are assigned no clinical group at all, which means a 30-day period cannot be grouped from them.
Every code in E20-E35
Descriptions are CMS’s own, abbreviated as CMS abbreviates them.
| Code | Description | Clinical group | Primary position |
|---|---|---|---|
| E200 | Idiopathic hypoparathyroidism | I | Accepted |
| E201 | Pseudohypoparathyroidism | I | Accepted |
| E20810 | Autosomal dominant hypocalcemia | I | Accepted |
| E20811 | Secondary hypoparathyroidism in diseases classd elswhr | None | Cannot group |
| E20812 | Autoimmune hypoparathyroidism | I | Accepted |
| E20818 | Oth hypoparathyroidism due to impaired PTH secretion | I | Accepted |
| E20819 | Hypoparathyroidism due to impaired PTH secretion, unsp | I | Accepted |
| E2089 | Other specified hypoparathyroidism | I | Accepted |
| E209 | Hypoparathyroidism, unspecified | I | Accepted |
| E210 | Primary hyperparathyroidism | I | Accepted |
| E211 | Secondary hyperparathyroidism, not elsewhere classified | I | Accepted |
| E212 | Other hyperparathyroidism | I | Accepted |
| E213 | Hyperparathyroidism, unspecified | I | Accepted |
| E214 | Other specified disorders of parathyroid gland | I | Accepted |
| E215 | Disorder of parathyroid gland, unspecified | None | Cannot group |
| E220 | Acromegaly and pituitary gigantism | I | Accepted |
| E221 | Hyperprolactinemia | I | Accepted |
| E222 | Syndrome of inappropriate secretion of antidiuretic hormone | I | Accepted |
| E228 | Other hyperfunction of pituitary gland | I | Accepted |
| E229 | Hyperfunction of pituitary gland, unspecified | None | Cannot group |
| E230 | Hypopituitarism | I | Accepted |
| E231 | Drug-induced hypopituitarism | I | Accepted |
| E232 | Diabetes insipidus | None | Cannot group |
| E233 | Hypothalamic dysfunction, not elsewhere classified | I | Accepted |
| E236 | Other disorders of pituitary gland | I | Accepted |
| E237 | Disorder of pituitary gland, unspecified | None | Cannot group |
| E240 | Pituitary-dependent Cushing's disease | I | Accepted |
| E241 | Nelson's syndrome | I | Accepted |
| E242 | Drug-induced Cushing's syndrome | I | Accepted |
| E243 | Ectopic ACTH syndrome | I | Accepted |
| E244 | Alcohol-induced pseudo-Cushing's syndrome | I | Accepted |
| E248 | Other Cushing's syndrome | I | Accepted |
| E249 | Cushing's syndrome, unspecified | I | Accepted |
| E250 | Congenital adrenogenital disorders assoc w enzyme deficiency | I | Accepted |
| E258 | Other adrenogenital disorders | I | Accepted |
| E259 | Adrenogenital disorder, unspecified | None | Cannot group |
| E2601 | Conn's syndrome | I | Accepted |
| E2602 | Glucocorticoid-remediable aldosteronism | I | Accepted |
| E2609 | Other primary hyperaldosteronism | I | Accepted |
| E261 | Secondary hyperaldosteronism | I | Accepted |
| E2681 | Bartter's syndrome | I | Accepted |
| E2689 | Other hyperaldosteronism | I | Accepted |
| E269 | Hyperaldosteronism, unspecified | None | Cannot group |
| E270 | Other adrenocortical overactivity | I | Accepted |
| E271 | Primary adrenocortical insufficiency | I | Accepted |
| E272 | Addisonian crisis | I | Accepted |
| E273 | Drug-induced adrenocortical insufficiency | I | Accepted |
| E2740 | Unspecified adrenocortical insufficiency | None | Cannot group |
| E2749 | Other adrenocortical insufficiency | None | Cannot group |
| E275 | Adrenomedullary hyperfunction | I | Accepted |
| E278 | Other specified disorders of adrenal gland | I | Accepted |
| E279 | Disorder of adrenal gland, unspecified | None | Cannot group |
| E280 | Estrogen excess | A | Accepted |
| E281 | Androgen excess | A | Accepted |
| E282 | Polycystic ovarian syndrome | I | Accepted |
| E28310 | Symptomatic premature menopause | A | Accepted |
| E28319 | Asymptomatic premature menopause | A | Accepted |
| E2839 | Other primary ovarian failure | A | Accepted |
| E288 | Other ovarian dysfunction | I | Accepted |
| E289 | Ovarian dysfunction, unspecified | None | Cannot group |
| E290 | Testicular hyperfunction | A | Accepted |
| E291 | Testicular hypofunction | I | Accepted |
| E298 | Other testicular dysfunction | I | Accepted |
| E299 | Testicular dysfunction, unspecified | None | Cannot group |
| E300 | Delayed puberty | None | Cannot group |
| E301 | Precocious puberty | None | Cannot group |
| E308 | Other disorders of puberty | None | Cannot group |
| E309 | Disorder of puberty, unspecified | None | Cannot group |
| E310 | Autoimmune polyglandular failure | I | Accepted |
| E311 | Polyglandular hyperfunction | A | Accepted |
| E3120 | Multiple endocrine neoplasia [MEN] syndrome, unspecified | I | Accepted |
| E3121 | Multiple endocrine neoplasia [MEN] type I | I | Accepted |
| E3122 | Multiple endocrine neoplasia [MEN] type IIA | I | Accepted |
| E3123 | Multiple endocrine neoplasia [MEN] type IIB | A | Accepted |
| E318 | Other polyglandular dysfunction | A | Accepted |
| E319 | Polyglandular dysfunction, unspecified | I | Accepted |
| E320 | Persistent hyperplasia of thymus | None | Cannot group |
| E321 | Abscess of thymus | A | Accepted |
| E328 | Other diseases of thymus | I | Accepted |
| E329 | Disease of thymus, unspecified | None | Cannot group |
| E3400 | Carcinoid syndrome, unspecified | I | Accepted |
| E3401 | Carcinoid heart syndrome | I | Accepted |
| E3409 | Other carcinoid syndrome | I | Accepted |
| E341 | Other hypersecretion of intestinal hormones | A | Accepted |
| E342 | Ectopic hormone secretion, not elsewhere classified | A | Accepted |
| E3430 | Short stature due to endocrine disorder, unspecified | I | Accepted |
| E3431 | Constitutional short stature | I | Accepted |
| E34321 | Primary insulin-like growth factor-1 (IGF-1) deficiency | I | Accepted |
| E34322 | Insulin-like growth factor-1 (IGF-1) resistance | I | Accepted |
| E34328 | Other genetic causes of short stature | I | Accepted |
| E34329 | Unspecified genetic causes of short stature | I | Accepted |
| E3439 | Other short stature due to endocrine disorder | I | Accepted |
| E344 | Constitutional tall stature | A | Accepted |
| E3450 | Androgen insensitivity syndrome, unspecified | None | Cannot group |
| E3451 | Complete androgen insensitivity syndrome | I | Accepted |
| E3452 | Partial androgen insensitivity syndrome | A | Accepted |
| E348 | Other specified endocrine disorders | I | Accepted |
| E349 | Endocrine disorder, unspecified | None | Cannot group |
| E35 | Disorders of endocrine glands in diseases classd elswhr | None | Cannot group |
Source: CMS HH PPS Grouper Software v07.1.26, effective 2026-04-01. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff.